sofosbuvir has been researched along with Dermatosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso López, S; Guerra Romero, AR; Pérez Figueras, M | 1 |
| Kamiya, K; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M; Waki, Y | 1 |
2 other study(ies) available for sofosbuvir and Dermatosclerosis
| Article | Year |
|---|---|
Successful evolution of morphea after hepatitis C virus eradication with direct-acting antiviral agent treatment.
Topics: Adult; Antiviral Agents; Benzimidazoles; Female; Fluorenes; Hepacivirus; Hepatitis C; Humans; Scleroderma, Localized; Sofosbuvir; Thigh; Uridine Monophosphate | 2019 |
Localized scleroderma occurring after treatment of chronic hepatitis C with sofosbuvir and ribavirin.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Male; Middle Aged; Ribavirin; Scleroderma, Localized; Skin; Sofosbuvir; Treatment Outcome | 2019 |